Regulation of c-kit+ progenitor cells by stromal cell derived factor-1α in adult murine heart

Heart Lung and Circulation

Volumn 23, Issue 1, 2014, Pages 75-81

  Chen, Zhongpu ^a   Pan, Xiaodong ^a   Yao, Yuyu ^a   Yan, Fengdi ^a   Chen, Long ^a   Huang, Rong ^a   Ma, Genshan ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

C kit; Cardiac progenitor cells; CXCR4; DNA methylation; DNA methyltransferase; Stromal cell derived factor 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; C KIT+ CARDIAC PROGENITOR CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL SELECTION; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STEM CELL; STEM CELL TRANSPLANTATION; UPREGULATION; WESTERN BLOTTING;

C-KIT; CARDIAC PROGENITOR CELLS; CXCR4; DNA METHYLATION; DNA METHYLTRANSFERASE; STROMAL CELL DERIVED FACTOR-1Α;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION REGULATION; MICE; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-KIT; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84891830741     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.05.652     Document Type: Article

References (36)

1. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabé-Heider F., Walsh S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
2. Kajstura J., Gurusamy N., Ogórek B., Goichberg P., Clavo-Rondon C., Hosoda T., et al. Myocyte turnover in the aging human heart. Circ Res 2010, 107:1374-1386.
3. D'Amario D., Fiorini C., Campbell P.M., Goichberg P., Sanada F., Zheng H., et al. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res 2011, 108:857-861.
4. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003, 100:12313-12318.
5. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
6. Urbanek K., Quaini F., Tasca G., Torella D., Castaldo C., Nadal-Ginard B., et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Sci USA 2003, 100:10440-10445.
7. Dawn B., Stein A.B., Urbanek K., Rota M., Whang B., Rastaldo R., et al. Cardiac stem cell delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci 2005, 102:3766-3771.
8. Smith R.R., Barile L., Cho H.C., Leppo M.K., Hare J.M., Messina E., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115:896-908.
9. Tang Y.L., Zhu W., Cheng M., Chen L., Zhang J., Sun T., et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarctionby inducing CXCR4 expression. Circ Res 2009, 104:1209-1216.
10. Linke A., Müller P., Nurzynska D., Casarsa C., Torella D., Nascimbene A., et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Sci USA 2005, 102:8966-8971.
11. Teyssier-Le, Discorde M., Prost S., Nandrot E., Kirszenbaum M. Spatial and temporal mapping of c-kit and its ligand, stem cell factor expression during human embryonic haemopoiesis. Br J Haematol 1999, 107:247-253.
12. Choi S.H., Jung S.Y., Suh W., Baek S.H., Kwon S.M. Establishment of isolation and expansion protocols for human cardiac c-kit-positive progenitor cells for stem cell therapy. Transplant Proc 2013, 45:420-426.
13. Kitamura Y., Hirotab S. Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci 2004, 61:2924-2931.
14. Wang K., Zhao X., Kuang C., Qian D., Wang H., Jiang H., et al. Overexpression of SDF-1α enhanced migration and engraftment of cardiac stem cells and reduced infarcted size via CXCR4/PI3 K pathway. PLoS ONE 2012, 7:e43922.
15. Leri A., Kajstura J., Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 2005, 85:1373-1416.
16. Ma J., Ge J., Zhang S., Sun A., Shen J., Chen L., et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 2005, 100:217-223.
17. Tang Y.L., Zhu W., Cheng M., Chen L., Zhang J., Sun T., et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 2009, 104:1209-1216.
18. Cheng M., Zhou J., Wu M., Boriboun C., Thorne T., Liu T., et al. CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity. Circ Res 2010, 107:1083-1093.
19. Miranda T.B., Jones P.A. DNA methylation: the nuts and bolts of repression. J Cell Physiol 2007, 213:384-390.
20. Dodge J.E., Ramsahoye B.H., Wo Z.G., Okano M., Li E. De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation. Gene 2002, 289:41-48.
21. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
22. You H., Ding W., Rountree C.B. Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta. Hepatology 2010, 51:1635-1644.
23. Yan F., Yao Y., Chen L., Li Y., Sheng Z., Ma G. Hypoxic preconditioning improves survival of cardiac progenitor cells: role of stromal cell derived factor-1α-CXCR4 axis. PLoS ONE 2012, 7:e37948.
24. Ehrich M., Nelson M.R., Stanssens P., Zabeau M., Liloglou T., Xinarianos G., et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 2005, 102:15785-15790.
25. Padin-Iruegas M.E., Misao Y., Davis M.E., Segers V.F., Esposito G., Tokunou T., et al. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation 2009, 120:876-887.
26. Kawaguchi N., Smith A.J., Waring C.D., Hasan M.K., Miyamoto S., Matsuoka R., et al. c-kitpos GATA-4 high rat cardiac stem cells foster adult cardiomyocyte survival through IGF-1 paracrine signalling. PLoS ONE 2010, 5:e14297.
27. Martin F.H., Suggs S.V., Langley K.E., Lu H.S., Ting J., Okino K.H., et al. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 1990, 63:203-211.
28. Möhle R., Moore M.A., Nachman R.L., Rafii S. Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line. Blood 1997, 89:72-80.
29. Kortesidis A., Zannettino A., Isenmann S., Shi S., Lapidot T., Gronthos S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 2005, 105:3793-3801.
30. Kucia M., Reca R., Miekus K., Wanzeck J., Wojakowski W., Janowska-Wieczorek A., et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005, 23:879-894.
31. Hu X., Dai S., Wu W.J., Tan W., Zhu X., Mu J., et al. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell-derived factor-1α-CXCR4 axis. Circulation 2007, 116:654-663.
32. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischemic cardiomyopathy. Lancet 2003, 362:697-703.
33. Tachibana K., Hirota S., Iizasa H., Yoshida H., Kawabata K., Kataoka Y., et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998, 393:591-594.
34. Fricker S.P., Anastassov V., Cox J., Darkes M.C., Grujic O., Idzan S.R., et al. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Biochem Pharmacol 2006, 72:588-596.
35. Stamatopoulos B., Meuleman N., De Bruyn C., Pieters K., Mineur P., Le Roy C., et al. AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: preclinical evidence for its association with chronic lymphocytic leukemia treatments. Haematologica 2012, 97:608-615.
36. Ikeda J.I., Morii E., Kimura H., Tomita Y., Takakuwa T., Hasegawa J.I., et al. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells. J Pathol 2006, 210:75-84.